Pooled Analysis of Outcomes of T1a/bN0, HER2-Amplified Breast Cancer.

被引：0
|
作者：
Amir, E. [1 ]
Seruga, B. [1 ]
Ocana, A. [1 ]
Carlsson, L. [1 ]
Bedard, P. [1 ]
机构：
[1] Princess Margaret Hosp, Toronto, ON M4X 1K9, Canada
来源：
CANCER RESEARCH | 2011年 / 71卷
关键词：
D O I：
10.1158/0008-5472.SABCS11-P2-12-07
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2-12-07
引用
收藏
页数：1
相关论文
共 50 条
  • [1] A Review of the Management of T1a/bN0 HER2-Overexpressed Breast Cancer
    Yap, Kelly Khai Li
    Tripathy, Debu
    [J]. AMERICAN JOURNAL OF HEMATOLOGY-ONCOLOGY, 2015, 11 (01) : 11 - 15
  • [2] Adjuvant chemotherapy in T1a/bN0 HER2-positive or triple-negative breast cancers: Application and outcomes
    Migdady, Yazan
    Sakr, Bachir J.
    Sikov, William M.
    Olszewski, Adam J.
    [J]. BREAST, 2013, 22 (05): : 793 - 798
  • [3] Disease-related outcomes with adjuvant chemotherapy in HER2 positive or triple negative T1a/bN0 breast cancers
    Shao, T.
    Olszewski, A. J.
    Boolbol, S. K.
    Migdady, Y.
    Boachie-Adjei, K.
    Sakr, B. J.
    Klein, P.
    Sikov, W.
    [J]. CANCER RESEARCH, 2012, 72
  • [4] Estrogen/Progesterone Receptor Negativity and HER2 Positivity Predict Locoregional Recurrence in Patients with T1a,bN0 Breast Cancer
    Albert, J. M.
    Gonzalez-Angulo, A. M.
    Guray, M.
    Sahin, A.
    Strom, E. A.
    Tereffe, W.
    Woodward, W. A.
    Tucker, S. L.
    Hortobagyi, G. N.
    Buchholz, T. A.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 75 (03): : S7 - S7
  • [5] ESTROGEN/PROGESTERONE RECEPTOR NEGATIVITY AND HER2 POSITIVITY PREDICT LOCOREGIONAL RECURRENCE IN PATIENTS WITH T1a,bN0 BREAST CANCER
    Albert, Jeffrey M.
    Gonzalez-Angulo, Ana M.
    Guray, Merih
    Sahin, Aysegul
    Strom, Eric A.
    Tereffe, Welela
    Woodward, Wendy A.
    Tucker, Susan L.
    Hunt, Kelly K.
    Hortobagyi, Gabriel N.
    Buchholz, Thomas A.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 77 (05): : 1296 - 1302
  • [6] Impact of Detection Method and Accompanying Ductal Carcinoma in Situ on Prognosis of T1a,bN0 Breast Cancer
    Shen, Shih-Che
    Ueng, Shir-Hwa
    Yang, Chan-Keng
    Yu, Chi-Chang
    Lo, Yung-Feng
    Chang, Hsien-Kun
    Lin, Yung-Chang
    Chen, Shin-Cheh
    [J]. JOURNAL OF CANCER, 2017, 8 (12): : 2328 - 2335
  • [7] Prognostic impact of adjuvant endocrine therapy for estrogen receptor-positive and HER2-negative T1a/bN0M0 breast cancer.
    Takahashi, Yuko
    Sasada, Shinsuke
    Kondo, Naoto
    Hashimoto, Hiroya
    Terata, Kaori
    Sagara, Yasuaki
    Naito, Yoichi
    Kida, Kumiko
    Ueno, Takayuki
    Anan, Keisei
    Suto, Akihiko
    Kanbayashi, Chizuko
    Takahashi, Mina
    Nakamura, Rikiya
    Ishiba, Toshiyuki
    Tsuneizumi, Michiko
    Nishimura, Seiichiro
    Hara, Fumikata
    Shien, Tadahiko
    Iwata, Hiroji
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [8] Adjuvant chemotherapy in T1a/bN0 breast cancer patients with high oncotype DX recurrence scores (RS>25)
    Katz, D.
    Feldhamer, I.
    Hammerman, A.
    Goldvaser, H.
    Goldstein, D.
    [J]. ANNALS OF ONCOLOGY, 2023, 34 : S284 - S284
  • [9] Age and Associated Fibrocystic Changes are Prognostically Significant in Patients with Small Node-Negative (T1a,bN0) Invasive Breast Cancer
    Durak, Merih Guray
    Gonzalez-Angulo, Ana M.
    Hanrahan, Emer O.
    Broglio, Kristine R.
    Valero, Vicente
    Hortobagyi, Gabriel N.
    Hunt, Kelly K.
    Sahin, Aysegul A.
    [J]. BREAST JOURNAL, 2011, 17 (05): : 462 - 469
  • [10] Patient Selection for Neoadjuvant Chemotherapy in cT1-T2/N0 HER2-Amplified Breast Cancer in the National Cancer Database
    Duchesneau, Emilie D.
    An, Selena J.
    Strassle, Paula D.
    Reeder-Hayes, Katherine
    Gallagher, Kristalyn K.
    Ollila, David W.
    Downs-Canner, Stephanie M.
    Spanheimer, Philip M.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (SUPPL 2) : S323 - S324
12345